Department of Experimental Neurology, Charité-University Medicine Berlin, Germany; Department of Neurology, Charité-University Medicine Berlin, Germany.
J Neuroimmunol. 2013 Nov 15;264(1-2):114-9. doi: 10.1016/j.jneuroim.2013.09.006. Epub 2013 Sep 18.
Whether there is a general perturbation of B and plasma cell subsets in myasthenia gravis (MG) has not been investigated so far. Here we performed a detailed flow cytometric analysis of blood and if available thymic tissue in order to detect MG-specific and therapy-induced changes. We observed significant differences in the distribution of B cell subsets in MG patients, yet these were mainly attributable to medical treatment. Furthermore MG is associated with significantly increased frequencies of plasma cells that were especially activated in purely ocular disease manifestation. In contrast to thymoma, B cell subset distribution in hyperplastic thymus could be distinguished from peripheral blood, however both tissues were not significantly enriched with plasma cells. Thus B cell differentiation in general is not defective in MG, but modified by therapy and enhanced frequencies of plasma cells can be detected in MG patients.
目前尚未研究重症肌无力 (MG) 患者体内 B 细胞和浆细胞亚群是否普遍受到干扰。在此,我们通过详细的流式细胞术分析了血液(如有可能还分析了胸腺组织),以检测 MG 特异性和治疗诱导的变化。我们观察到 MG 患者的 B 细胞亚群分布存在显著差异,但这些差异主要归因于治疗方法。此外,MG 患者的浆细胞频率显著升高,特别是在单纯眼肌疾病表现的患者中。与胸腺瘤不同,增生性胸腺中的 B 细胞亚群分布可与外周血区分开来,但这两种组织均未显著富含浆细胞。因此,MG 患者的 B 细胞分化总体上并未出现缺陷,而是受到治疗的影响,并且可以检测到浆细胞的频率增加。